Search
for
Sort by
Research 31–60 of 90
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Anticancer effects of metformin on neuroendocrine tumor cells in vitro
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- Prophylaxis and Management of Skin Toxicities
- Viremia and viruria of trichodysplasia spinulosa‐associated polyomavirus before the development of clinical disease in a kidney transplant recipient
- Knowledge Mapping of Drug Repositioning’s Theme and Development
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Management of a Refractory EIF3E-RSPO2 Fusion Positive Pilomatrical Cancer Patient with Encyclopedic Tumor Analysis Guided Treatment
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Integrin signalling regulates YAP/TAZ to control skin homeostasis
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Tumor Angiogenesis and Anti-angiogenic Therapy
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities
- The regulation of skin homeostasis, repair and the pathogenesis of skin diseases by spatiotemporal activation of epidermal mTOR signaling
- Formononetin: A Pathway to Protect Neurons
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Premature aging syndromes: From patients to mechanism
- Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation
- Molecular pathways involved in hair follicle tumor formation: all about mammalian target of rapamycin?
- Long‐term outcome after hand and forearm transplantation – a retrospective study
- Management of Dermatologic Toxicities
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Design and Validation of a Sensitive Multisteroid LC-MS/MS Assay for the Routine Clinical Use: One-Step Sample Preparation with Phospholipid Removal and Comparison to Immunoassays
- Establishment of Tsc2-deficient rat embryonic stem cells
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients